The $750 pill
Bavencio, a new cancer drug approved earlier this year by the U.S. Food and Drug Administration, costs about $156,000 a year per patient.Late last year, a new muscular dystrophy drug was approved that costs about $300,000 a year per patient.And a new bladder cancer treatment called Tecentriq costs $150,000 a year per patient.And who can forget the national public relations disaster …
Please sign in to continue.
Become a valued Chicago Lawyer subscriber today and receive:
- 12 monthly print editions mailed.
- Access to chicagolawyermagazine.com and our e-edition.
- Bimonthly news and informational emails.
- Special editions such as Forty Under 40, Practice Resource Guides and much, much more!.
Call (312) 644-2394 or subscribe now.